Article
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against…
medRxiv · 2021 · Franck Touret, author Jean-Sélim Driouich, author Maxime Cochin, author Paul Rémi Petit, author Magali Gilles, author Karine Barthélémy, author Grégory Moureau, author Francois-Xavier Mahon, author Denis Malvy, author Caroline Solas, author Xavier de Lamballerie, author Antoine Nougairède, author
Key facts
| Title | Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2 |
|---|---|
| First author | Franck Touret, author Jean-Sélim Driouich, author Maxime Cochin, author Paul Rémi Petit, author Magali Gilles, author Karine Barthélémy, author Grégory Moureau, author Francois-Xavier Mahon, author Denis Malvy, author Caroline Solas, author Xavier de Lamballerie, author Antoine Nougairède, author |
| Journal | medRxiv |
| Published | Jan 26, 2021 |
| DOI | 10.1101/2020.11.17.386904 |
| Devices mentioned | BK110039, K123955 |
| Product codes mentioned | JJH, KIT, NJT, OOI, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1